News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GANNON STEVEN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2021 |
4
| GANNON STEVEN (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Bought 6,000 shares
@ $8.1, valued at
$48.6k
|
|
| 06/07/2021 |
4
| GANNON STEVEN (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 17,000 options to buy
@ $8.15, valued at
$138.6k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| GANNON STEVEN (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 141,011 options to buy
@ $2.35, valued at
$331.4k
Granted 30,000 options to buy
@ $17, valued at
$510k
|
|
| 06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/02/2020 |
4
| GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 10,000 options to buy
@ $13.11, valued at
$131.1k
|
|
| 09/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2018 |
4
| GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 15,000 options to buy
@ $6.2, valued at
$93k
|
|
| 08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2017 |
4
| GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 3,500 options to buy
@ $3.85, valued at
$13.5k
|
|
|
|